Cargando…
The Experience of Fertility Preservation in a Single Tertiary Center in Korea
OBJECTIVE: Oocyte (OC), embryo (EC), and ovarian tissue cryopreservation (OTC) are options for fertility preservation (FP) before going through gonadotoxic cancer treatment, or anticipated fertility decline in benign ovarian diseases, or for planned OC. The aim of this study is to report outcomes of...
Autores principales: | Choi, Yae Ji, Hong, Yeon Hee, Kim, Seongbeen, Kim, Seul Ki, Lee, Jung Ryeol, Suh, Chang Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062070/ https://www.ncbi.nlm.nih.gov/pubmed/35518927 http://dx.doi.org/10.3389/fendo.2022.845051 |
Ejemplares similares
-
Utility of Blood Markers for Predicting Outcomes of Fertility Preservation in Patients With Breast Cancer
por: Hong, Yeon Hee, et al.
Publicado: (2022) -
The Significance of Planned Fertility Preservation for Women With Endometrioma Before an Expected Ovarian Cystectomy
por: Hong, Yeon Hee, et al.
Publicado: (2021) -
Fertility preservation for patients with breast cancer: The Korean Society for Fertility Preservation clinical guidelines
por: Kim, Hoon, et al.
Publicado: (2017) -
Editorial: Fertility Preservation in Asia
por: Lee, Jung Ryeol, et al.
Publicado: (2021) -
Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
por: Hong, Yeon Hee, et al.
Publicado: (2022)